Boehringer Ingelheim Vetmedica Inc. (BIVI) has closed a deal with Pfizer to acquire a significant portion of the Fort Dodge Animal Health business. The acquisition, which includes products in the U.S., Australia, Canada and South Africa, as well as two manufacturing and research facilities located in Fort Dodge, Iowa, significantly increases the size of Boehringer Ingelheim’s companion animal and cattle portfolios and strengthens the company’s position as a leading vaccine supplier.
I talked with BIVI president George Heidgerken about the acquisition. “We’ll be expanding our business significantly, in fact, doubling our sales in the United States,” George says. “The product assets we’ve acquired from Fort Dodge are a broad range of strong brands in the cattle vaccine business. This is part of our long term strategy to improve our product offerings and our capabilities for the U.S. cattle producers and the U.S. cattle market.”
The cattle vaccines included in the acquisition include the Triangle®, Pyramid®, and Presponse® vaccine lines. Pharmaceutical products being acquired include Cydectin® (moxidectin) for cattle and sheep as well as Polyflex® (ampicillin sodium). The dairy portfolio includes the key brands Today® and Tomorrow®.
“With regard to the brands we are acquiring, it’s business as usual,” George added. “The producers and veterinarians and distributors who handle and benefit from these wonderful brands will really see no significant change.”
Listen to or download my interview with George here:

Phase II of the
David Bennett with the Western Farm Press just posted this news alert about
The
There’s a new copywriter at
Jim Langcuster at Auburn University recently published an article in the Southeast Farm Press titled, 
Their ag database has 2.5 million U.S. farmers and ranchers. They can pull specific farmographic data like number of acres, type of crop and how they own that farm. They also cross reference the farm data with their residential database of 220 million consumers as well as a business database of 14 million of which about 1 million are specific to ag. Clients range from technology to seed to irrigation and includes small business and Fortune 500 companies.
“They’re our primary customer at the end of the day and we can have the greatest technologies, the greatest genetics but if we don’t understand their business and the challenges they face, it could all be wasted,” said Agronomy Marketing Manager Bruce Battles at a recent ag media day at Syngenta Seeds new headquarters in Minnetonka, Minn.